{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:53:58Z","timestamp":1789480438156,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"am","delay-in-days":279,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006761","name":"Bureau of Educational and Cultural Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bcp.2025.116970","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T19:08:25Z","timestamp":1746212905000},"page":"116970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Nanomolar therapeutic concentrations of statins rapidly induce cerebral artery vasoconstriction by stimulating L-type calcium channels"],"prefix":"10.1016","volume":"238","author":[{"given":"Farzana","family":"Zerin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreelakshmi N.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuella","family":"Ezewudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimi P.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Sooreni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashmum S.","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin","family":"G\u00f6k\u00e7e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taufiq","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquibul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2025.116970_b0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2025.116970_b0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5519","key":"10.1016\/j.bcp.2025.116970_b0015","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"issue":"6257","key":"10.1016\/j.bcp.2025.116970_b0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.bcp.2025.116970_b0025","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1101\/gad.11.18.2295","article-title":"Rho GTPases and signaling networks","volume":"11","author":"Van Aelst","year":"1997","journal-title":"Genes Dev"},{"issue":"6","key":"10.1016\/j.bcp.2025.116970_b0030","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/MCB.00989-10","article-title":"Therapeutic levels of the hydroxmethylglutaryl-coenzyme A reductase inhibitor lovastatin activate ras signaling via phospholipase D2","volume":"31","author":"Cho","year":"2011","journal-title":"Mol Cell Biol"},{"issue":"37","key":"10.1016\/j.bcp.2025.116970_b0035","doi-asserted-by":"crossref","first-page":"24266","DOI":"10.1074\/jbc.273.37.24266","article-title":"Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase","volume":"273","author":"Laufs","year":"1998","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.bcp.2025.116970_b0040","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2025.116970_b0045","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.arabjc.2011.06.025","article-title":"Pleiotropic effects of statins: a boulevard to cardioprotection","volume":"9","author":"Rohilla","year":"2016","journal-title":"Arab. J. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2025.116970_b0050","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleiotropic effects of statins. - Basic research and clinical perspectives","volume":"74","author":"Zhou","year":"2010","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.bcp.2025.116970_b0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.CIR.0000020682.73694.AB","article-title":"Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase","volume":"106","author":"Takemoto","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.bcp.2025.116970_b0060","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1161\/01.STR.0000181077.84981.11","article-title":"Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection","volume":"36","author":"Rikitake","year":"2005","journal-title":"Stroke"},{"issue":"6736","key":"10.1016\/j.bcp.2025.116970_b0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/21224","article-title":"Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation","volume":"399","author":"Dimmeler","year":"1999","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2025.116970_b0070","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2174\/1381612820666141013134447","article-title":"Adverse effects of statins - myths and reality","volume":"21","author":"\u0160imi\u0107","year":"2015","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.bcp.2025.116970_b0075","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jalz.2016.08.013","article-title":"Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease","volume":"13","author":"Leeuwis","year":"2017","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.bcp.2025.116970_b0080","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1177\/0271678X20982383","article-title":"Causes and consequences of baseline cerebral blood flow reductions in Alzheimer's disease","volume":"41","author":"Bracko","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"10.1016\/j.bcp.2025.116970_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220473","article-title":"Simvastatin causes pulmonary artery relaxation by blocking smooth muscle ROCK and calcium channels: evidence for an endothelium-independent mechanism","volume":"14","author":"Absi","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2025.116970_b0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2125.2011.03907.x","article-title":"What is a relevant statin concentration in cell experiments claiming pleiotropic effects?","volume":"72","author":"Bj\u00f6rkhem-Bergman","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2025.116970_b0095","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/pgs.09.85","article-title":"Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin","volume":"10","author":"Keskitalo","year":"2009","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.bcp.2025.116970_b0100","first-page":"616","article-title":"Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitor","volume":"40","author":"Stern","year":"2000","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.bcp.2025.116970_b0105","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1248\/bpb.32.1600","article-title":"A simple and sensitive HPLC-UV method for quantitation of lovastatin in human plasma: application to a bioequivalence study","volume":"32","author":"Hamidi","year":"2009","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"10.1016\/j.bcp.2025.116970_b0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00005344-199603000-00011","article-title":"Simvastatin releases Ca2+ from a thapsigargin-sensitive pool and inhibits InsP3-dependent Ca2+ mobilization in vascular smooth muscle cells","volume":"27","author":"Escobales","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2025.116970_b0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00005344-199907000-00016","article-title":"Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity","volume":"34","author":"Tesfamariam","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"10.1016\/j.bcp.2025.116970_b0120","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.bjp.0706114","article-title":"Effects of statins on vascular function of endothelin-1","volume":"144","author":"Mraiche","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2025.116970_b0125","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/abbs\/gmw009","article-title":"Atorvastatin blocks increased l-type Ca2+ current and cell injury elicited by angiotensin II via inhibiting oxide stress","volume":"48","author":"Ma","year":"2016","journal-title":"Acta Biochim. Biophy. Sin."},{"issue":"2\u20133","key":"10.1016\/j.bcp.2025.116970_b0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(01)00819-6","article-title":"Effect of simvastatin on vascular smooth muscle responsiveness: involvement of Ca(2+) homeostasis","volume":"415","author":"Alvarez de Sotomayor","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"9364","key":"10.1016\/j.bcp.2025.116970_b0135","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2025.116970_b0140","doi-asserted-by":"crossref","unstructured":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial, Lancet 360 (9326) (2002) 7\u201322.","DOI":"10.1016\/S0140-6736(02)09327-3"},{"issue":"6","key":"10.1016\/j.bcp.2025.116970_b0145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bcp.2025.116970_b0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jphs.2022.09.004","article-title":"Mechanism of canagliflozin-induced vasodilation in resistance mesenteric arteries and the regulation of systemic blood pressure","volume":"150","author":"Hasan","year":"2022","journal-title":"J Pharmacol Sci"},{"issue":"19","key":"10.1016\/j.bcp.2025.116970_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910842","article-title":"Empagliflozin relaxes resistance mesenteric arteries by stimulating multiple smooth muscle cell voltage-gated K(+) (K(V)) channels","volume":"22","author":"Hasan","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.bcp.2025.116970_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09503","article-title":"Dapagliflozin induces vasodilation in resistance-size mesenteric arteries by stimulating smooth muscle cell K(V)7 ion channels","volume":"8","author":"Hasan","year":"2022","journal-title":"Heliyon"},{"issue":"52","key":"10.1016\/j.bcp.2025.116970_b0165","doi-asserted-by":"crossref","first-page":"27095","DOI":"10.1073\/pnas.1917264116","article-title":"SUMO1 modification of PKD2 channels regulates arterial contractility","volume":"116","author":"Hasan","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.bcp.2025.116970_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110413","article-title":"Transient receptor potential canonical type 3 channels control the vascular contractility of mouse mesenteric arteries","volume":"9","author":"Yeon","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2025.116970_b0175","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/CIRCRESAHA.117.311102","article-title":"Endothelin-1 stimulates vasoconstriction through Rab11A Serine 177 phosphorylation","volume":"121","author":"Zhai","year":"2017","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.bcp.2025.116970_b0180","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/HYPERTENSIONAHA.118.11147","article-title":"Impaired trafficking of \u03b21 subunits inhibits BK channels in cerebral arteries of hypertensive rats","volume":"72","author":"Leo","year":"2018","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.bcp.2025.116970_b0185","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/CIRCRESAHA.110.216804","article-title":"Isoform-selective physical coupling of TRPC3 channels to IP3 receptors in smooth muscle cells regulates arterial contractility","volume":"106","author":"Adebiyi","year":"2010","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.bcp.2025.116970_b0190","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/CIRCRESAHA.108.173948","article-title":"IP3 constricts cerebral arteries via IP3 receptor\u2013mediated TRPC3 channel activation and independently of sarcoplasmic reticulum Ca2+ release","volume":"102","author":"Xi","year":"2008","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bcp.2025.116970_b0195","doi-asserted-by":"crossref","first-page":"C1376","DOI":"10.1152\/ajpcell.00362.2008","article-title":"Type 1 inositol 1,4,5-trisphosphate receptors mediate UTP-induced cation currents, Ca2+ signals, and vasoconstriction in cerebral arteries","volume":"295","author":"Zhao","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"10.1016\/j.bcp.2025.116970_b0200","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/CIRCRESAHA.110.224345","article-title":"Mitochondria control functional CaV1.2 expression in smooth muscle cells of cerebral arteries","volume":"107","author":"Narayanan","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2025.116970_b0205","unstructured":"J.P.A. Bannister, A. Adebiyi, G.-l. Zhao, D. Narayanan, C.M. Thomas, J.Y. Feng, J.H. Jaggar, Smooth Muscle Cell 2-1 Subunits Are Essential for Vasoregulation by CaV 1 . 2 Channels, 2009."},{"issue":"1","key":"10.1016\/j.bcp.2025.116970_b0210","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1038\/s41598-020-71449-1","article-title":"Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways","volume":"10","author":"Hasan","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.bcp.2025.116970_b0215","doi-asserted-by":"crossref","first-page":"14659","DOI":"10.1038\/s41598-020-71599-2","article-title":"Canagliflozin ameliorates renal oxidative stress and inflammation by stimulating AMPK\u2013Akt\u2013eNOS pathway in the isoprenaline-induced oxidative stress model","volume":"10","author":"Hasan","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.116970_b0220","doi-asserted-by":"crossref","DOI":"10.1093\/bioadv\/vbad078","article-title":"Improvement of protein tertiary and quaternary structure predictions using the ReFOLD refinement method and the AlphaFold2 recycling process","volume":"3","author":"Adiyaman","year":"2023","journal-title":"Bioinform Adv"},{"issue":"4","key":"10.1016\/j.bcp.2025.116970_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26041134","article-title":"Establishing an analogue based in silico pipeline in the pursuit of novel inhibitory scaffolds against the SARS coronavirus 2 papain-like protease","volume":"26","author":"Hajbabaie","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.116970_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107662","article-title":"Proposed model of the Dictyostelium cAMP receptors bound to cAMP","volume":"100","author":"Greenhalgh","year":"2020","journal-title":"J Mol Graph Model"},{"issue":"6","key":"10.1016\/j.bcp.2025.116970_b0235","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/cmdc.200700010","article-title":"From modeling to medicinal chemistry: automatic generation of two-dimensional complex diagrams","volume":"2","author":"Stierand","year":"2007","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.bcp.2025.116970_b0240","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1038\/s41598-022-08877-8","article-title":"Neflamapimod induces vasodilation in resistance mesenteric arteries by inhibiting p38 MAPK\u03b1 and downstream Hsp27 phosphorylation","volume":"12","author":"Pandey","year":"2022","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.bcp.2025.116970_b0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046735","article-title":"Statins and selective inhibition of Rho kinase protect small conductance calcium-activated potassium channel function (K(Ca)2.3) in cerebral arteries","volume":"7","author":"McNeish","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.116970_b0250","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42628","article-title":"Arterial smooth muscle cell PKD2 (TRPP1) channels regulate systemic blood pressure","volume":"7","author":"Bulley","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2025.116970_b0255","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2018.08.031","article-title":"Comparison of signalling mechanisms underlying UTP-evoked vasoconstriction of rat pulmonary and tail arteries","volume":"837","author":"Tengah","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.bcp.2025.116970_b0260","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1073\/pnas.1317527111","article-title":"Dynamic regulation of \u03b21 subunit trafficking controls vascular contractility","volume":"111","author":"Leo","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.bcp.2025.116970_b0265","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/1570159X12666140923210929","article-title":"The many roles of statins in ischemic stroke","volume":"12","author":"Zhao","year":"2014","journal-title":"Curr Neuropharmacol"},{"issue":"11","key":"10.1016\/j.bcp.2025.116970_b0270","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/01.STR.28.11.2315","article-title":"Vascular Effects of Statins in Stroke","volume":"28","author":"Delanty","year":"1997","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.bcp.2025.116970_b0275","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cell.2019.04.043","article-title":"Molecular basis for ligand modulation of a mammalian voltage-gated Ca(2+) channel","volume":"177","author":"Zhao","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bcp.2025.116970_b0280","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1002\/anie.202011793","article-title":"Structural basis of the modulation of the voltage-gated calcium ion channel Ca(v) 1.1 by dihydropyridine compounds*","volume":"60","author":"Gao","year":"2021","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"10.1016\/j.bcp.2025.116970_b0285","doi-asserted-by":"crossref","DOI":"10.1080\/19336950.2023.2290807","article-title":"Structural biology of voltage-gated calcium channels","volume":"18","author":"Yao","year":"2024","journal-title":"Channels (austin)"},{"issue":"1","key":"10.1016\/j.bcp.2025.116970_b0290","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1038\/s41467-024-47116-8","article-title":"Structural bases of inhibitory mechanism of Ca(V)1.2 channel inhibitors","volume":"15","author":"Wei","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.bcp.2025.116970_b0295","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41422-024-00959-8","article-title":"Structural basis for human Cav3.2 inhibition by selective antagonists","volume":"34","author":"Huang","year":"2024","journal-title":"Cell Res."},{"issue":"10","key":"10.1016\/j.bcp.2025.116970_b0300","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.ATV.0000142813.33538.82","article-title":"Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase\/protein kinase Akt and cardiovascular protection","volume":"24","author":"Wolfrum","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bcp.2025.116970_b0305","doi-asserted-by":"crossref","unstructured":"X. Wang, B. He, Endothelial dysfunction: molecular mechanisms and clinical implications, MedComm (2020) 5(8) (2024) e651.","DOI":"10.1002\/mco2.651"},{"issue":"2","key":"10.1016\/j.bcp.2025.116970_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/ph15020151","article-title":"Beyond lipid-lowering: effects of statins on cardiovascular and cerebrovascular diseases and cancer","volume":"15","author":"Morofuji","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bcp.2025.116970_b0315","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40035-018-0110-3","article-title":"The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms","volume":"7","author":"Schultz","year":"2018","journal-title":"Transl Neurodegener"},{"issue":"1","key":"10.1016\/j.bcp.2025.116970_b0320","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11883-024-01255-x","article-title":"Do statins affect cognitive health? A narrative review and critical analysis of the evidence","volume":"27","author":"Kazibwe","year":"2024","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"10.1016\/j.bcp.2025.116970_b0325","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020214","article-title":"Potential benefits and risks associated with the use of statins","volume":"16","author":"Khatiwada","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.116970_b0330","unstructured":"O.S.S.K.P.P.R. Talati, Statin Medications, Treasure Island (FL): StatPearls (Updated 2024 Feb 29)."},{"issue":"6","key":"10.1016\/j.bcp.2025.116970_b0335","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/joim.13134","article-title":"Statin exposure and the risk of dementia in individuals with hypercholesterolaemia","volume":"288","author":"Lee","year":"2020","journal-title":"J. Intern. Med."},{"issue":"21","key":"10.1016\/j.bcp.2025.116970_b0340","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jacc.2019.09.041","article-title":"Effects of statins on memory, cognition, and brain volume in the elderly","volume":"74","author":"Samaras","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.bcp.2025.116970_b0345","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2015.03.021","article-title":"Genetics of cardiovascular disease: importance of sex and ethnicity","volume":"241","author":"Winham","year":"2015","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.bcp.2025.116970_b0350","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009217.pub2","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"2013","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.bcp.2025.116970_b0355","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/jch.12081","article-title":"Antihypertensive effects of statins: a meta-analysis of prospective controlled studies","volume":"15","author":"Briasoulis","year":"2013","journal-title":"J Clin Hypertens (greenwich)"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225002321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225002321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:00:47Z","timestamp":1785499247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225002321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":71,"alternative-id":["S0006295225002321"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116970","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomolar therapeutic concentrations of statins rapidly induce cerebral artery vasoconstriction by stimulating L-type calcium channels","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116970"}}